Product Information
ARFORMOTEROL 15 MCG/2 ML SOLN is a generic product labeled by Devatis Inc., priced at $0.6328 per ML under NDC 73043005293. Its NADAC has been published 38 times since Jan 14, 2026.
FDA first approved this application on Apr 25, 2025. Its Orange Book therapeutic-equivalence code is AN.
Strength
15 ug/2mL
Manufacturer
Devatis Inc.NDC
73043005293
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ARFORMOTEROL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA218429FDA Approved
4/25/2025
TE Code
AN
On Market Since
8/1/2025
Pharmacological Classes
Price Statistics
The NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has been published 38 times since Jan 14, 2026, and over the history we have for it it has declined 7.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6328 per ML |
|---|---|
| All-time high | $0.6838 (Jan 14, 2026) |
| All-time low | $0.5426 (Jun 17, 2026) |
| 52-week high | $0.6838 |
| 52-week low | $0.5426 |
| Median price | $0.6145 |
| Average price | $0.6121 |
| Largest weekly change | +9.6% (Jul 22, 2026) |
| Weeks tracked | 38 |
| Tracking since | Jan 14, 2026 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Devatis Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Arformoterol Tartrate Inhalation market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARFORMOTEROL 15 MCG/2 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for ARFORMOTEROL 15 MCG/2 ML SOLN, manufactured by Devatis Inc., is $0.6328 per ML (NDC 73043005293), effective Sep 30, 2026.
How has the price of ARFORMOTEROL 15 MCG/2 ML SOLN changed over time?
Over the history we have for it, the NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has declined 7.5%. It has been tracked across 38 weekly CMS publications since Jan 14, 2026.
What are the highest and lowest recorded NADAC prices for ARFORMOTEROL 15 MCG/2 ML SOLN?
Since Jan 14, 2026, the NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has ranged from a low of $0.5426 (Jun 17, 2026) to a high of $0.6838 (Jan 14, 2026), with a median of $0.6145 per ML.
Are there cheaper alternatives to ARFORMOTEROL 15 MCG/2 ML SOLN?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARFORMOTEROL 15 MCG/2 ML SOLN, is $0.6202 per ML — about 2% below ARFORMOTEROL 15 MCG/2 ML SOLN.
Who manufactures ARFORMOTEROL 15 MCG/2 ML SOLN?
ARFORMOTEROL 15 MCG/2 ML SOLN (NDC 73043005293) is labeled by Devatis Inc., and CMS classifies it as a generic product.